Last updated: November 28, 2022
Sponsor: University of California, San Francisco
Overall Status: Active - Recruiting
Phase
N/A
Condition
Congestive Heart Failure
Chest Pain
Heart Failure
Treatment
N/AClinical Study ID
NCT03586336
RADAR-HF
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients hospitalized for acute decompensated heart failure requiring treatment withintravenous diuretics and/or IV vasoactive drugs
- Patient has signed informed consent and has authorized use and disclosed healthinformation
- Patient is at least 18 years of age
- Patient physically suitable for ReDS measurement
- GFR>25
- Initial ReDS Measurement >35%
Exclusion
Exclusion Criteria:
- Patient characteristics excluded from approved use of ReDS system: height less than 155cm or greater than 190cm, BMI <22 or >39, chest circumference <80cm or >115cm , orflail chest
- Evidence of focal lung lesions on history, physical exam or chest x-ray, includinghistory of pulmonary embolism, active pneumonia, or known lung nodule
- Chronic renal failure (GFR<25)
- Prior cardiac surgery within 2 months of index admission
- Patient has a ventricular assist device or has had a cardiac transplantation
- Patients in cardiogenic shock at admission requiring inotropic support
- Congenital heart malformations or intra-thoracic mass that would affect right-lunganatomy (e.g dextrocardia, lung carcinoma, or pacemaker box in the right chest)
Study Design
Total Participants: 100
Study Start date:
December 01, 2018
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
University of California, San Francisco
San Francisco, California 94143
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.